Our collaborative research on targeted cancer therapeutics using multiplexed CRISPR/Cas9 has been published in Cancer Research. This study was successfully achieved through a joint effort with the research groups of Prof. Seung Woo Cho, Prof. Tae-Eun Park, Prof. Taejoon Kwon, and Prof. Kyungjae Myung. The technology enhances precise therapeutic efficacy by specifically targeting mutated DNA within cancer cells.
Kyunghwan Kim from our laboratory, along with Soyoung Lee (Prof. Cho’s lab) and Hye-Jin Jeong (Prof. Park’s lab), contributed equally as co-first authors. This milestone marks a major contribution from our group in the advancement of specialized CRISPR delivery platforms. Congratulations to all the co-authors on this great achievement!